Table 1.
Baseline characteristics of the patients with alcoholic hepatitis and healthy controls.
Fig 1.
Functional hepatic nitrogen clearance in patients with non-severe and severe alcoholic hepatitis and healthy controls.
Functional hepatic nitrogen clearance (FHNC) in patients with non-severe (GAHS<9, N = 9) and severe (GAHS≥9, N = 11) alcoholic hepatitis and healthy controls (N = 7). The solid horizontal lines indicate the mean values. The FHNC was decreased in the AH patients compared with the healthy controls (P<0.01) and the largest decrease was observed in those with severe AH (P<0.05).
Fig 2.
Relationship between the functional hepatic nitrogen clearance and galactose elimination capacity.
Relationship between the functional hepatic nitrogen clearance (FHNC) and galactose elimination capacity (GEC) in patients with non-severe (hollow circles) (GAHS<9, N = 8) and severe (circles) (GAHS≥9, N = 10) alcoholic hepatitis. No significant correlation was observed between the FHNC and GEC.
Fig 3.
Relationship between the functional hepatic nitrogen clearance and Model for End-Stage Liver Disease score.
Relationship between the functional hepatic nitrogen clearance (FHNC) and Model for End-Stage Liver Disease (MELD) score in patients with non-severe (hollow circles) (GAHS<9, N = 9) and severe (circles) (GAHS≥9, N = 11) alcoholic hepatitis. The linear regression line shows the correlation (rho = -0.49; P<0.05).
Table 2.
Plasma hormone and glucose levels measured before (t = -60 min) and after intravenous alanine infusion (t = 360 min) in patients with alcoholic hepatitis and in healthy controls.